How much funding has Genomenon raised?

Genomenon has raised $44.1M in total funding, most recently a Series B round.

Who are Genomenon's investors?

Genomenon's investors include Beringea, Spring Mountain Capital, Michigan Angel Fund, BroadOak Capital Partners, Green Park & Golf Ventures, Red Cedar Ventures.

Where is Genomenon headquartered?

Genomenon is headquartered in Ann Arbor, Michigan, United States.

What industry is Genomenon in?

Genomenon operates in Biotech, Genomics, Healthcare, Artificial Intelligence.

How many employees does Genomenon have?

Genomenon has 51-200 employees.

Genomenon

Genomic Evidence at the Gene and Variant Level

Ann Arbor, United States · Founded 2014 · $44.1M raised

Biotech

Genomics

Healthcare

Artificial Intelligence

Headquarters: Ann Arbor, Michigan
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: genomenon.com
Total Funding: $44.1M
Last Round: $5.5M Series BMay 2024
Rounds: 9

About

Genomenon is an AI-powered genomic intelligence company that transforms biomedical literature into actionable variant insights for clinical diagnostics and precision medicine. Its Mastermind platform organizes evidence across 27 million genomic variants, helping over 250 clinical labs and 75 pharma programs accelerate rare disease diagnosis and drug development.

Summary

Genomenon is a Biotech company based in Ann Arbor, United States, founded in 2014. It has raised $44.1M in total across 9 rounds, most recently a $5.5M Series B round in May 2024. Investors include Beringea, Spring Mountain Capital and Michigan Angel Fund.

LinkedIn X (Twitter)